COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review
<p dir="ltr">Although the possibility of asymptomatic course for COVID-19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID-19 is important as the progression is still not clear.</p><h2>Other Information</h2><p dir=&...
محفوظ في:
| المؤلف الرئيسي: | Lina Okar (14777164) (author) |
|---|---|
| مؤلفون آخرون: | Mohammad Ali (73095) (author), Jabeed Parengal (12535533) (author), Mohamed A. Yassin (8361183) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis
حسب: Mohamed A. Yassin (16322749)
منشور في: (2020) -
The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review
حسب: Nasrallah, Gheyath K.
منشور في: (2020) -
Luspatercept's use in a patient with transfusion‐dependent beta‐thalassemia and intrathoracic extramedullary hematopoiesis (EMH)
حسب: Mohammed Najdat Seijari (17563263)
منشور في: (2024) -
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
حسب: Hiam Chemaitelly (439114)
منشور في: (2024) -
BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
حسب: Hiam Chemaitelly (439114)
منشور في: (2024)